Latest Health News

Page 75 of 235
OMG Group has reported a record-breaking November with $720,000 in sales, driving a 68% revenue increase year-to-date. Strong ecommerce and retail growth set the stage for a promising summer season.
Victor Sage
Victor Sage
4 Dec 2025
Nuix Limited has announced its acquisition of Paris-based graph intelligence firm Linkurious for up to €20 million, aiming to enhance its AI-driven data analytics capabilities and expand its global footprint.
Sophie Babbage
Sophie Babbage
4 Dec 2025
Queste Communications reported a slight net cash outflow from operations in November 2025 but maintains robust liquidity supported by a substantial loan facility and liquid ASX-listed investments.
Claire Turing
Claire Turing
3 Dec 2025
QPM Energy Limited has had its trading suspension lifted following the announcement of a strategic investment term sheet and a capital raising, signaling renewed momentum for the energy company.
Maxwell Dee
Maxwell Dee
3 Dec 2025
Microequities Asset Management Group delivered a robust November trading update, driven by strong returns in its Pure Microcap Value Fund and a final performance payment from a special purpose vehicle, pushing half-year profits above last year’s level.
Claire Turing
Claire Turing
3 Dec 2025
Mach7 Technologies has inked a five-year subscription agreement with UnityPoint Health, marking the first commercial deployment of its new Flamingo Architecture and setting the stage for significant recurring revenue growth.
Victor Sage
Victor Sage
3 Dec 2025
BTC Health has reissued its Chairman’s Address with added financial details, highlighting a strategic shift towards diversified medical products and a strong start to FY26 with 36% revenue growth.
Ada Torres
Ada Torres
3 Dec 2025
LTR Pharma has secured ethics approval for its Phase II SPONTAN clinical trial, focusing on pharmacokinetics and dosing in men aged 65 and older. Recruitment begins early 2026 with initial results expected mid-year.
Ada Torres
Ada Torres
3 Dec 2025
Nexsen Limited has appointed internationally acclaimed surgeon-scientist Professor Shekhar Kumta to its board, aiming to fast-track clinical validation and regulatory approval for its rapid diagnostic platforms ahead of a planned 2026 market entry.
Ada Torres
Ada Torres
3 Dec 2025
Microba Life Sciences has secured a $3.06 million R&D tax incentive refund for FY25, reinforcing its cash reserves and supporting ongoing advancements in gastrointestinal diagnostics and clinical therapeutics.
Ada Torres
Ada Torres
3 Dec 2025
Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.
Ada Torres
Ada Torres
3 Dec 2025
Control Bionics Limited is set to acquire the remaining stake in Neuro Elite Athletics, integrating the NeuroBounce athletic performance program with its EMG technology to accelerate growth in key markets.
Victor Sage
Victor Sage
3 Dec 2025